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Abstract We have studied the effect of guanosine-5P-O-(3-
thiotriphosphate) (GTP-Q-S), a non-hydrolyzable analogue of
GTP, on agonist and antagonist binding to bovine hippocampal
5-hydroxytryptamine (5-HT)1A receptor in native membranes.
Our results show that the specific binding of the agonist is
inhibited with increasing concentrations of GTP-Q-S along with a
reduction in binding affinity. In sharp contrast to this, antagonist
binding to 5-HT1A receptor shows no significant reduction and
remains invariant over a large range of GTP-Q-S concentrations.
The binding affinity of the antagonist also remains unaltered.
This shows that the agonist and the antagonist differentially
discriminate G-protein coupling of 5-HT1A receptors from bovine
hippocampus.
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1. Introduction
Serotonin (5-hydroxytryptamine (5-HT)) is an intrinsically
£uorescent [1], biogenic amine which acts as a neurotransmit-
ter and is found in a wide variety of sites in the central and
peripheral nervous systems [2]. Serotonergic signalling appears
to play a key role in the generation and modulation of various
cognitive and behavioral functions including sleep, mood,
pain, addiction, locomotion, sexual activity, depression, anxi-
ety, alcohol abuse, aggression and learning [3^5]. Disruptions
in serotonergic systems have been implicated in the etiology of
mental disorders such as schizophrenia, migraine, depression,
suicidal behavior, infantile autism, eating disorders and obses-
sive compulsive disorder [4,6,7].
Serotonin exerts its diverse actions by binding to distinct
cell surface receptors which have been classi¢ed into many
groups [8]. Serotonin receptors are members of a superfamily
of seven transmembrane domain receptors [9] that couple to
GTP binding regulatory proteins (G-proteins). Among the
various types of serotonin receptors, the G-protein-coupled
5-HT1A receptor subtype has been the most extensively
studied for a number of reasons [10]. We have recently parti-
ally puri¢ed and solubilized the 5-HT1A receptor from bovine
hippocampus in a functionally active form [11] and have
shown modulation of receptor binding by metal ions [10]
and alcohols [12].
Since most seven transmembrane domain receptors are
coupled to G-proteins [13], guanine nucleotides are known
to regulate agonist binding. The 5-HT1A receptor is negatively
coupled to the adenylate cyclase system through G-proteins
[14]. We report here that agonist binding to the 5-HT1A re-
ceptor is sensitive to guanine nucleotides. However, antago-
nist binding to the 5-HT1A receptor is found to be insensitive
to guanine nucleotides. This could be due to the binding of
the agonist only to those receptors which are coupled to G-
proteins, while the antagonist binds to all receptors irrespec-
tive of their state of G-protein coupling.
2. Materials and methods
Fresh bovine brains were obtained from a local slaughterhouse
within 10 min of death and the hippocampal region was carefully
dissected out. The hippocampi were immediately £ash frozen in liquid
nitrogen and stored at 370‡C until further use. Native membranes
were prepared as described earlier [12]. Bovine hippocampal tissue
(V120 g) was homogenized as 10% (w/v) in a polytron homogenizer
in bu¡er A (2.5 mM tris-(hydroxymethyl)aminomethane (Tris), 0.32
M sucrose, 5 mM ethylenediaminetetraacetic acid (EDTA), 5 mM
ethylene glycol bis(L-aminoethylether)-N,N,NP,NP-tetraacetic acid,
0.02% sodium azide, 0.24 mM phenylmethylsulfonyl £uoride
(PMSF), 10 mM iodoacetamide, pH 7.4). The homogenate was cen-
trifuged at 900Ug for 10 min at 4‡C. The supernatant was ¢ltered
through four layers of cheese cloth and the pellet was discarded. The
supernatant was further centrifuged at 50 000Ug for 20 min at 4‡C.
The resulting pellet was suspended in 10 volumes of bu¡er B (50 mM
Tris, 1 mM EDTA, 0.24 mM PMSF, 10 mM iodoacetamide, pH 7.4)
using a hand-held Dounce homogenizer and centrifuged at 50 000Ug
for 20 min at 4‡C. This procedure was repeated until the supernatant
was clear. The ¢nal pellet was resuspended in a minimum volume of
50 mM Tris bu¡er (pH 7.4), homogenized using a Dounce homoge-
nizer, £ash frozen in liquid nitrogen and stored at 370‡C for radio-
ligand binding assays.
Agonist binding assays were performed with varying concentrations
of guanosine-5P-O-(3-thiotriphosphate) (GTP-Q-S) (Boehringer Mann-
heim, Germany) as follows. Tubes in triplicate containing 1 mg of
total protein were incubated for 1 h at room temperature with 0.29
nM [3H]8-hydroxy-2-(di-N-propylamino)tetralin (OH-DPAT) (Du-
Pont New England Nuclear, Boston, MA, USA: speci¢c activity
127.0 Ci/mmol) in a total volume of 1 ml of bu¡er C (50 mM Tris,
1 mM EDTA, 10 mM MgCl2, 5 mM MnCl2, pH 7.4). Non-speci¢c
binding was determined by performing the assay in the presence of 10
WM unlabelled serotonin. The incubation was terminated by rapid
¢ltration under vacuum in a Millipore multiport ¢ltration apparatus
through Whatman GF/B (1.0 Wm pore size) 2.5 cm diameter glass
micro¢ber ¢lters (Whatman International, Kent, UK) which were
pre-soaked in 0.3% polyethylenimine for 3 h [15]. The ¢lters were
then washed three times with 3 ml of ice-cold water, dried and the
retained radioactivity was measured in a Packard Tri-Carb 1500 scin-
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tillation counter using 5 ml of scintillation £uid. Antagonist binding
assays in the presence of GTP-Q-S were performed as above using
[3H]4-(2P-methoxy)-phenyl-1-(2P-(N-2PP-pyridinyl)-p-£uorobenzamido)-
ethyl-piperazine (p-MPPF) (DuPont New England Nuclear, Boston,
MA, USA; speci¢c activity 64.6 Ci/mmol) as the radioligand. The
assay tubes contained 0.5 nM [3H]p-MPPF in a total volume of 1 ml
of bu¡er D (50 mM Tris, 1 mM EDTA, pH 7.4). Non-speci¢c binding
was determined by performing the assay in the presence of 10 WM
unlabelled 4-(2P-methoxy)-phenyl-1-(2P-(N-2PP-pyridinyl)-p-iodobenz-
amido)ethyl-piperazine (p-MPPI) (a kind gift from Dr V. Bakthava-
chalam, National Institute of Mental Health Chemical Synthesis Pro-
gram, Research Biochemicals International). Protein concentration
was determined using bicinchoninic acid reagent (Pierce, Rockford,
IL, USA) [16].
Saturation binding assays were carried out using varying concen-
trations (0.1^7.5 nM) of radiolabelled agonist ([3H]OH-DPAT) or
antagonist ([3H]p-MPPF) using native membranes containing 1 mg
of total protein. Non-speci¢c binding was measured in the presence
of 10 WM unlabelled 5-HT (for agonist) or p-MPPI (for antagonist).
Binding assays were carried out at room temperature as mentioned
above in the presence of high (100 WM) and low (1 nM) concentra-
tions of GTP-Q-S. Control experiments were carried out without GTP-
Q-S. Binding data were analyzed as described earlier [10]. The concen-
tration of bound ligand was calculated from the equation:
RL  1039UB=VUSAU2220M
where B = bound radioactivity in desintegrations per minute (dpm)
(i.e. total dpm5non-speci¢c dpm), V is the assay volume in ml and
SA is the speci¢c activity of the radioligand. Scatchard plots (i.e. plots
of RL*/L* versus RL*) were analyzed using Sigma-Plot (version 3.1)
in an IBM PC. The dissociation constants (Kd) were obtained from
the negative inverse of the slopes, determined by linear regression
analysis of the plots (r = 0.92^0.99). The binding parameters shown
in Table 2 were obtained by averaging the results of three independent
experiments while saturation binding data shown in Figs. 3 and 4 are
from representative experiments.
3. Results and discussion
Among the various types of serotonin receptors, the G-pro-
tein-coupled 5-HT1A receptor subtype has been the most ex-
tensively studied. One of the major reasons for this is the early
availability of a highly selective agonist, OH-DPAT, that al-
lows extensive biochemical, physiological and pharmacologi-
cal characterization of the receptor [17]. Fig. 1 shows the
inhibition of speci¢c OH-DPAT binding to bovine hippocam-
pal 5-HT1A receptor in native membranes by GTP-Q-S, a non-
hydrolyzable analogue of GTP, in a characteristic concentra-
tion-dependent manner [10]. This shows that the bovine hip-
pocampal 5-HT1A receptor is coupled to G-proteins and GTP-
Q-S induces a transition of the receptor from a high a⁄nity to
a low a⁄nity state. It has previously been reported that OH-
DPAT binds to the high a⁄nity binding sites of only that
population of 5-HT1A receptors which is coupled to G-pro-
teins [18].
Although selective 5-HT1A agonists (e.g. OH-DPAT) have
been discovered more than a decade ago [17], the development
of selective 5-HT1A antagonists has been relatively slow and
less successful. Recently, p-MPPI and p-MPPF have been in-
troduced as selective antagonists for the 5-HT1A receptor [19^
22]. These compounds bind speci¢cally to 5-HT1A receptor
with a high a⁄nity. Fig. 2 shows the e¡ect of varying con-
centrations of GTP-Q-S on speci¢c p-MPPF binding to the 5-
HT1A receptors in native membranes. In sharp contrast to
what is observed with agonist binding, the antagonist binding
shows no dependence on GTP-Q-S over a large range of con-
centrations (1 nM^100 WM) used, i.e. the antagonist binding is
independent of GTP-Q-S. Furthermore, there is a slight (10^
Fig. 1. E¡ect of increasing concentrations of GTP-Q-S on the specif-
ic binding of the agonist [3H]OH-DPAT to the 5-HT1A receptor
from bovine hippocampal membranes. Values are expressed as a
percentage of the speci¢c binding obtained in the absence of GTP-Q-
S. The data points are the means þ S.E.M. of triplicate points from
three independent experiments. See Section 2 for other details.
Fig. 2. E¡ect of increasing concentrations of GTP-Q-S on the specif-
ic binding of the antagonist [3H]p-MPPF to the 5-HT1A receptor
from bovine hippocampal membranes. Values are expressed as a
percentage of the speci¢c binding obtained in the absence of GTP-Q-
S. The data points are the means þ S.E.M. of triplicate points from
four independent experiments. See Section 2 for other details.
Table 1
Speci¢c activities for [3H]OH-DPAT and [3H]p-MPPF binding to
5-HT1A receptors from bovine hippocampal membranesa
Ligand Speci¢c binding activityb
(fmol/mg of protein)
[3H]OH-DPAT (agonist) 76.2 þ 6.4
[3H]p-MPPF (antagonist) 120.9 þ 11.3
aFor details of binding assays, see Section 2.
bData reported are mean þ S.E.M. of ¢ve independent experiments.
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20%) increase in binding in the presence of GTP-Q-S. Table 1
shows that the speci¢c activity obtained using the agonist
[3H]OH-DPAT is 76.2 fmol/mg protein while that obtained
using the antagonist [3H]p-MPPF is 120.9 fmol/mg. There is
thus aV60% increase in speci¢c activity when [3H]p-MPPF is
used. This further suggests that while the agonist [3H]OH-
DPAT binds to only that population of 5-HT1A receptors
that is coupled to G-proteins [18], the antagonist [3H]p-
MPPF binds to both G-protein-coupled and free receptor
giving rise to a higher speci¢c activity. Comparing the speci¢c
activity values obtained with the agonist and the antagonist,
therefore, can provide an idea of the extent of G-protein cou-
pling of 5-HT1A receptors in the system.
Figs. 3 and 4 show the Scatchard analysis of the speci¢c
binding of [3H]OH-DPAT and [3H]p-MPPF to the 5-HT1A
receptor in bovine hippocampal membranes in the presence
of high and low concentrations of GTP-Q-S. The binding pa-
rameters under these conditions are summarized in Table 2.
The binding a⁄nity of [3H]OH-DPAT shows a considerable
reduction at high concentrations (100 WM) of GTP-Q-S, con-
¢rming that the receptor is in a low a⁄nity state at high GTP-
Q-S concentrations. This is in agreement with Fig. 1 which
shows that at high GTP-Q-S concentrations, the low a⁄nity
form of the receptor predominates. Table 2 also shows that
the binding a⁄nity of [3H]p-MPPF in the presence of 100 WM
GTP-Q-S shows no signi¢cant variation. This supports our
previous conclusion that antagonist binding is independent
of GTP-Q-S (see Fig. 2).
In summary, we show here that the speci¢c agonist OH-
DPAT and the antagonist MPPF bind to 5-HT1A receptors
from bovine hippocampal membranes and exhibit di¡erent
sensitivities to guanine nucleotides. This di¡erence can be po-
tentially exploited to gain a better understanding of signal
transduction processes triggered by the 5-HT1A receptor.
These results are relevant to ongoing analyses of the overall
modulation of G-protein coupling in seven transmembrane
domain receptors.
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